News and Trends 9 Jan 2023
ErVaccine raises €4.5M to start therapeutic cancer vaccine trial
ErVaccine Technologies, announces the closing of a €4.5 million ($4.8 million) seed round, including dilutive and non-dilutive funds, with Seventure and Bpifrance as part of the Aide au Développement de…